T he ELANA technique facilitates the construction of an end-to-side anastomosis between a donor vessel and a recipient artery without the need to occlude the recipient artery temporarily. It therefore eliminates ischemic risk for the patient during anastomosis construction. The technique is mainly used in bypass grafting on proximal cerebral arteries. [5] [6] [7] [11] [12] [13] It was shown in a longterm study in pigs that ELANA allows patency, flow, and endothelialization comparable to that achieved with conventional anastomoses. 4 The ELANA technique is technically challenging. In Utrecht we have trained more than 100 neurosurgeons from 24 countries in the past decade. These were mostly excellent vascular neurosurgeons with thorough microsurgical training. However, they still encountered a long, steep learning curve.
T he ELANA technique facilitates the construction of an end-to-side anastomosis between a donor vessel and a recipient artery without the need to occlude the recipient artery temporarily. It therefore eliminates ischemic risk for the patient during anastomosis construction. The technique is mainly used in bypass grafting on proximal cerebral arteries. [5] [6] [7] [11] [12] [13] It was shown in a longterm study in pigs that ELANA allows patency, flow, and endothelialization comparable to that achieved with conventional anastomoses. 4 The ELANA technique is technically challenging. In Utrecht we have trained more than 100 neurosurgeons from 24 countries in the past decade. These were mostly excellent vascular neurosurgeons with thorough microsurgical training. However, they still encountered a long, steep learning curve.
We therefore developed a new version of the technique, the so-called sutureless ELANA (SELANA). The SELANA technique eliminates the use of intracranial microsutures. It was shown in a rabbit model 10 and in a pressurized human cadaver model 8 that SELANA is easier and faster than ELANA, and that it is associated with less damage to surrounding structures because less movement is necessary to attach the anastomosis.
In the current study we assessed flow, patency, and endothelialization of the SELANA technique in a survival model in pigs. We hypothesized that these results would not be inferior compared with the flow, patency, and endothelialization results of the ELANA technique in an earlier survival study in pigs. 4 Patency, flow, and endothelialization of the sutureless Excimer Laser Assisted Non-occlusive Anastomosis (ELANA) technique in a pig model
Methods
This study was approved by the animal experimentation committee of Utrecht University, the Netherlands. Experiments were performed in the ISO-9001 certified animal laboratory of Utrecht University. This study was conducted according to the regulations of Good Laboratory Practice as defined by the FDA and the Organization for Economic Cooperation and Development, and according to the standards as detailed in the Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Research, National Research Council. Washington, DC: National Academy Press, 1996).
Experimental Animals
For this study we used 38 female Dutch Landrace pigs. We operated when the pigs weighed a mean of 30 ± 4 kg (means are expressed ± SD throughout). Preoperatively and postoperatively, the pigs received a normal diet. All animals received 1 daily dose of aspirin (80 mg) from 5 days before the surgical procedure until the day the animal was killed.
In our earlier pig study, short-term endothelialization assessment was difficult because the shortest survival was 2 weeks. We therefore added more short-term survival intervals to the current study, resulting in 12 intervals, as follows: 1 day (2 pigs), 2 days (2), 3 days (2), 4 days (2), 5 days (2), 6 days (2), 1 week (2), 10 days (3), 2 weeks (3), 3 weeks (3), 3 months (7), and 6 months (7). One extra animal underwent the operation and then was killed 1 hour after bypass opening, while the pig was still in a state of general anesthesia, to serve as control for endothelialization analysis.
Anesthesia Protocol
As premedication we intravenously administered midazolam (0.2 mg/kg) and ketamine (10 mg/kg). Subsequently, we induced anesthesia intravenously with thiopental (3-8 mg/kg, depending on the level of sedation after premedication) and atropine (0.5 mg). Then we intubated the animal and placed it supine on the operating table. A continuous saline infusion was started (300 ml/hour) with sufentanil (first a 0.1-mg/kg bolus, then 0.1 mg/kg/hour), midazolam (first a 0.2-mg/kg bolus, then 0.2 mg/kg/hour) and pancuronium (first a 0.05-mg/kg bolus, then 0.05 mg/kg/hour). We used this protocol for surgery and planned death, because just before the animal was killed an angiogram was made. The animals were killed with an overdose of sodium pentobarbital delivered after angiography and removal of the bypass.
Bypass Procedure
In 38 pigs a left CCA bypass was created, in which the right CCA was used as an interposition jump graft. All procedures were performed by the first author (T.P.C.v.D.), together with one of the other authors. A midline incision of approximately 15 cm was made in the neck (Fig. 1A) . The right CCA was exposed and excised over a length of 10 cm. The artery was cut into 2 pieces and preserved in a heparin-saline solution (50 IU/ml). Subsequently, the left CCA was exposed. The rest of the procedure was performed using the operating microscope (OPMI MD S3, Carl Zeiss, Inc.). The periadventitial tissue was removed from the left CCA, leaving the adventitial layer exposed.
Subsequently, 2 SELANA rings were attached to the 2 right CCA grafts. The SELANA ring consisted of an MR imaging-compatible stainless steel ring with 2 pins. We used 3 stitches of 8-0 Prolene to retract the 2 flaps over the SELANA ring (Fig. 1B and C) . Eventually extra stitches were applied at the side above the ring. Attachment of the SELANA ring to the CCA took a mean of 9.6 ± 2.1 minutes per ring. This is comparable to the mean conventional ELANA ring attachment time of 10.9 ± 1.3 minutes in our earlier experiments. 10 After 24 procedures, we slightly changed the shape of the SELANA pins, from straight to curved. In this variant, the upper ring is positioned flatter on the recipient artery wall, while the longitudinal part of the pins "rests" on the recipient artery wall ( Fig. 2A and B) .
The next step was the attachment of the 2 bypass grafts, by using the attached SELANA devices, to the recipient vessel (Fig. 1D ). The SELANA device was grasped at the back, between the 2 pins, with a straight 21.5-cm Jacobson microneedle holder with catch (Scanlan International). The SELANA pins were pushed through the left CCA wall, and subsequently translated under the wall toward the planned parent vessel occlusion ( Fig. 1D and E). When the longitudinal parts of the pins were completely under the arterial wall, and resistance of the circumferential part was felt, the pins were directed upward again to puncture the recipient artery wall inside out. The circumferential parts of the pins were "clicked" under the recipient artery wall with this movement, leaving the pins resting on the outside (Fig. 1D ). The 2 anastomoses were then sealed with 4 small pieces of TachoSil (Nycomed, Inc.) (Fig. 1F) .
The anastomosis was subsequently opened using the laser (16.6 mJ at 40 pulses per second in 3 laser episodes of 5 seconds each) with the aid of an ELANA catheter (Elana bv) (Fig. 1G) . Because the wall of the CCA in these pigs (0.3-0.4 mm) was slightly thicker than the normal human recipient artery-for example, the ICA or MCA (0.1-0.2 mm) 4 -the ELANA catheter was technically adapted; the distance from the tip of the fibers to the grid was increased from 0.3 to 0.4 mm, and the laser energy was increased from 10 to 16.6 mJ.
When laser cutting was successful, a full-thickness piece of recipient artery wall (the so-called flap) was retrieved at the suction portion of the catheter tip. 9 Subsequently we put an aneurysm clip on the bypass graft and checked the anastomosis for patency and leakage. Any leakage from the anastomosis that was self-limiting or that could be controlled by brief local pressure with a small piece of gauze was defined as "oozing." If temporary occlusion was necessary to control the leakage, the bleeding was defined as "brisk." After the laser was used to open each of the 2 anastomoses and to control eventual leakage, 5000 IU of heparin were intravenously administered as a bolus.
Subsequently, a conventional running end-to-end anastomosis was made as described before (Fig. 1H) .
After finishing the end-to-end anastomosis, a temporary clip was put on the left CCA underneath the bypass. If the bypass showed steady or increasing flow during the first 15 minutes, we replaced the temporary clip on the left CCA with 2 definitive hemoclips (Figs. 1I and 2C) and surgically closed the wound in layers.
Flow Assessment
Flow measurements were performed using a dedicated single-vessel flowmeter (Transonic Systems, Inc.; Fig.  2C ). Before attaching the bypass, the left CCA flow was measured. During the procedure, flow through the bypass was measured during at least the initial 15 minutes after The SELANA device was first slid over the removed right CCA, a small tail was cut at the back, and was flipped between the back of the pins. At the back, the small tail was attached to the large front flapped tail with 2 Prolene sutures (8-0) above the ring and pins, not fully penetrating the arterial wall. C: The large front tail was flipped anteriorly between the pins and the ring. It was attached at the anterior side to the arterial wall with 1 stitch of 8-0 Prolene, not fully penetrating the arterial wall. D: The SELANA device, including the bypass graft, is slid into the left CCA. The pins puncture the wall and are first positioned under the vessel wall. By then tilting it and subsequently transposing the device forward, the straight part of the pins slide inside out again while the circumferential part of the pins "clicks" under the recipient wall. E: The insertion of the SELANA devices was in the direction of the final vessel occlusion. F: The SELANA anastomoses were sealed with TachoSil. G: The anastomoses were opened using the laser, with the aid of an ELANA 2.0 catheter. H: End-to-end anastomosis. The recipient CCA remains patent during this procedure. I: Bypass in situ with definitive occlusion of the recipient CCA.
the bypass was finished. At the animals' planned death, the flow through the bypass was measured again.
Patency Assessment
In each animal, an angiogram was performed to check bypass patency at follow-up, after induction of general anesthesia, via a sheath in the femoral artery (Fig. 3 ). In the 3-and 6-month subgroups, a separate control angiogram was made after 3 weeks, with the pig in a state of general anesthesia. If the bypass was closed at that point, the animal was killed.
Endothelialization Assessment
In each of the survival subgroups, 2 anastomoses were analyzed using a previously described SEM technique. 4 As a control, 1 anastomosis, in the control animal that had been killed immediately (3 hours) after the procedure, was also analyzed with SEM.
At least 2 other anastomoses per survival subgroup and the anastomosis in the control animal that was killed at 3 hours were histologically analyzed. For this purpose, the anastomoses were put in formalin immediately after removal from the pig. Subsequently, the anastomoses were embedded in plastic. After a 7-day fixation, thin slices were made with a diamond saw (this was necessary because of the steel ring) and stained with H & E.
Statistical Analysis
To assess differences in patency, leakage rates, and flap retrieval rates of the SELANA versus the historical ELANA control group, we used Fisher exact tests. To assess differences in time intervals and bypass flows in the pig between this SELANA study and historical data, we used nonpaired t-tests. To assess differences in flows at different time intervals in the same bypass, we used paired t-tests. For all statistical analyses, SPSS version 15.0 was used. Means are stated ± SD unless otherwise indicated. We regarded a p value < 0.05 as statistically significant.
Results

Findings for Anastomoses
In total, 38 bypass procedures were performed, with 76 SELANAs (Table 1) . No device-related complications were observed during the SELANA application. The mean SELANA application time, including reapplication and sealing of the anastomoses, was 7 ± 2 minutes. This was significantly faster than the mean ELANA application time of 45 ± 9 minutes recorded earlier in the same location in pigs by Streefkerk et al. 4 (p < 0.01). After opening using the laser with the ELANA catheter, the flap was found on the catheter tip in 69 (91%) of the 76 anastomoses. The flap was not retrieved by the catheter in 7 anastomoses (in 5 bypasses). In 3 of these 7 anastomoses, we had used a malfunctioning catheter, which was only determined after the experiment was finished. In 2 other anastomoses we unintentionally used a conventional catheter with a more superficial grid. These 5 missed flaps were removed manually through an extra horizontal side cut in the bypass graft close to the anastomosis under temporary occlusion (mean duration 1.5 ± 0.3 minutes). In the other 2 anastomoses in which we missed the flap, we were not able to retrieve it manually. When the animal was killed, we observed that we had positioned the catheter incorrectly and had used the laser partially outside the ring. This resulted in both cases in endothelial damage and a "moon like" opening without a flap.
After catheter retraction, 24 (32%) of the 76 SELANA anastomoses oozed, compared with 14 (50%) of the 28 ELANA anastomoses in the earlier ELANA study. 4 This difference is not statistically significant. The oozing in the 24 SELANA anastomoses was observed during the first 24 procedures, increasing oozing percentage until that moment to 50% (24 of 48 total connections). During these procedures we noted that leakage always occurred at the same side of the SELANA anastomosis; at the frontal side between the 2 pins at the exit point of the recipient artery wall. For this reason we then slightly changed the shape of the pins in a bayonet configuration. This positioned the ring and the tips of the pins more flush with the recipient artery wall ( Fig. 2A and B) . Anastomotic leakage was not observed during the remaining procedures. In total, 3 (4%) of the 76 SELANA anastomoses leaked briskly after use of the laser, compared with 4% of the ELANA anastomoses in our earlier study 4 (nonsignificant difference). The so-called brisk SELANA leakage was caused by insufficient sealant application in 2 anastomoses, and in 1 anastomosis by detachment of the sealant as a result of incorrect movement by the surgeon during catheter extraction. After extra sealant application, all 3 anastomoses were totally dry. In our earlier ELANA study in a porcine model, all brisk leakages were solved with an extra stitch.
Blood Flow
The flow in the left CCA before bypass attachment was 296 ± 63 ml/min. The mean flow through the bypasses just after opening was 160 ± 56 ml/min. After 15 minutes, the mean bypass flow had slightly increased, to 172 ± 37 ml/min. At planned death, the mean bypass flow in the 33 patent bypasses had increased to 192 ± 70 ml/ min, which was not a significant increase compared with flow at opening. The SELANA bypass flows tended to be higher than flows in the earlier ELANA pig study. The differences, however, were not significant (Table 1) .
Bypass Patency
All bypasses were patent just before skin closure, as shown by flow measurements. At short-term angiographic follow-up (all 12 subgroups, with follow-up a maximum of 3 weeks), 33 (87%) of the 38 bypasses were patent (Table 1 ). All 5 occlusions were observed on the 3-week control angiogram in animals in the 2 long-term survival groups (3 and 6 months). These animals were killed at that point.
At the long-term follow-up of the remaining 9 bypasses in the 2 long-term follow-up subgroups, no occlusions occurred anymore. Therefore, total bypass patency ‡ Three of the 7 bypasses in the 3-month subgroup and 2 of the 7 in the 6-month subgroup appeared to be occluded on the control angiogram at 3 weeks. § Two bypasses occluded acutely, which was observed while the animal was still in a state of anesthesia. The third bypass occluded in the 2-week subgroup, and the fourth occluded in the 6-month subgroup; both were observed at planned death. was 87%. This is not significantly different from the earlier ELANA study, in which 24 (86%) of 28 bypasses remained patent.
In total, 7 flaps were not directly retrieved in 5 bypasses. Of these 5 bypasses, 3 occluded. Of the remaining 33 bypasses, 2 occluded, which is significantly less (p = 0.01). Although the data set is very small, this could suggest that the manual retrieval of the flap in this model negatively influenced bypass patency.
In all 9 bypasses that remained in situ long term (3 and 6 months), arterial remodeling and growth from the recipient CCA was visible on angiography (Fig. 3B) and at macroscopic assessment (Fig. 4B) . This caused upward displacement and angulation of the SELANA device. The SELANA ring remained perpendicular to the bypass graft in all cases. The distance of the SELANA ring to the CCA wall ranged from 0.5 to 1.5 mm. The remodeling occurred both in proximal and distal anastomoses, and did not cause any complications (for example, hemorrhages or occlusions). Arterial remodeling was also visible in the earlier ELANA pig study (Fig. 4A) . No other irregularities, such as pseudoaneurysm formation at the site of the SELANA anastomosis, were observed.
In 6 bypasses, the lumen of the graft was increased to a diameter larger than that of the SELANA ring (2.8 mm) at long-term follow-up, causing a slight relative stricture at the location of the SELANA device (Fig. 3B) . There was no association with a lower bypass flow or patency.
Graft Endothelialization
In the acute stage (1 hour after bypass completion) there was a clear demarcation between bypass graft, laser edge, pin, and recipient artery (Figs. 5A and 6A ). The endothelial cell layers of the donor and recipient artery were still totally intact. The different layers of the recipient artery (intima, media, and adventitia) could be clearly distinguished on the laser edge, which was covered by platelet aggregates and fibrin deposits (Fig. 5A) .
During the first week, an increasing amount of activated thrombocytes with long villuslike protrusions could be found between the bypass graft and laser edge, and over the pin. At 10 days, the laser edge was retracted (Fig. 5B) and endothelialized (Fig. 6B) . Also, the pin was partially endothelialized at 10 days, but the edge between the bypass graft and recipient CCA was not yet (Fig. 7A) . Endothelialization of the pin originated from both sites where the pin penetrated the recipient arterial wall. At 3 weeks, endothelialization of the pin and endothelialization of the edge between the bypass graft and the laser edge resulted in total anastomosis endothelialization (Figs. 5C, 6C, 7B, and 7C) . At 3 and 6 months, the ring, still covered by endothelium (Fig. 5D) , was more visible from inside the anastomosis, because the anastomosis expanded over the device (Fig. 6D) .
Discussion
The objective of this study was to assess the flow, patency, and endothelialization of the SELANA technique in a pig model and to compare these results with the earlier ELANA study of Streefkerk et al. 4 in the same pig model. The most important findings of the current study were 3-fold. First, this study showed a noninferior flow of the SELANA compared with the ELANA bypass at opening and follow-up. Second, this study showed a noninferior patency of the SELANA compared with the ELANA anastomosis. Third, this study showed that the endothelialization process of the SELANA anastomosis is finished after approximately 3 weeks. This seems slightly longer than the endothelialization of the conventional ELANA anastomosis in the identical model, which took approximately 2 weeks. 4 
Other Studies
In an earlier study in 42 rabbits, we showed that the showing clear demarcation between (from upper to lower panels) bypass graft, laser edge, pin, and recipient artery. The endothelial cell layers of the donor and recipient artery are completely intact. The different layers of the recipient artery (intima, media, and adventitia) can be clearly distinguished on the laser edge, which is covered by platelet aggregates and fibrin deposits. On the pin only a few thrombocytes are attached. B: At 10 days of survival. The laser edge is retracted and endothelialized. The border between the donor artery and recipient is still visible. Endothelium has started to grow over the pin, preceded by activated thrombocytes and fibrin, which adhere to the smooth surface of the pin (see detail on far right, with precursor cells attached to the pin surface). C: At 3 weeks of survival. The SELANA device is completely endothelialized, and is visible as a single layer. D: At 6 months of survival. The endothelial layer over the device is thinner because the anastomosis has expanded within and ultimately slightly over the device. However, no spots without endothelium are visible.
SELANA technique combined with TachoSil was feasible, and it was faster and easier to perform than the current ELANA technique. 10 In a second study in 4 pressurized human cadaver heads, we showed that the SELANA technique was feasible intracranially. 8 The SELANA required less space than the ELANA technique, which resulted in less brain retraction. The SELANA technique could facilitate an anastomosis in locations at which it is extremely difficult or even impossible to suture the conventional ELANA in 1 or more quadrants, for example on the ICA close to the optic nerve, on the PCA (P 1 part) next to the third cranial nerve or perforating vessels, or even on the BA. Moreover, because of the extreme simplification of the SELANA technique, the anastomosis time was reduced from hours to minutes. The results of these earlier studies combined with the results of the current study support a SELANA pilot study in humans. This will reveal if patients truly benefit from these technological advances.
Current Study
The current study was performed in a pig model because of this model's resemblance to human physiology, including coagulation and histology, making it realistic and critical. The diameter of the SELANA ring was 2.8 mm, which is identical to what would be used on the ICA, proximal MCA, or PCA. However, the SELANA ring was adapted to the CCA of the pig, which is slightly thicker than a healthy ICA.
Recipient vessel wall thickness in patients poses a theoretical problem, because variations in this thickness, for example between the ICA and PCA, can be significant. Moreover, there is a large variation between patients in donor vessel wall thickness. As donor grafts, theoretically both the radial artery and saphenous vein could be used in patients. Their thickness cannot be exactly predicted preoperatively. Because we anticipate these problems, we plan to make different rings with different distances of the pins from the ring. An alternative for the future could be a clip mechanism at the back of the SELANA device.
However, this further technical development is still in an experimental phase in our laboratories.
Methodological Drawback
The current study does not have an ELANA control group, but uses the results of Streefkerk et al. 4 in 2005 as control data. This theoretically could have biased the SELANA results, because during the performance of this study we were aware of previous results.
Moreover, the 2 studies had some methodological differences. First, more animals underwent the operation in the current study, and they were divided into more short-term follow-up groups. This was decided based on the finding in the earlier study by Streefkerk et al. that all ELANA anastomoses were already endothelialized in the first follow-up group at 2 weeks. With more short-term follow-up groups we could study the endothelialization process in more detail. Second, in the earlier ELANA study, the bypasses were constructed with 1 conventional and 1 ELANA anastomosis. We chose to use 2 SELANA anastomoses because we learned from the first study that if a thrombosed bypass is found, it could be difficult to attribute the cause to one of the anastomoses specifically. Third, the primary surgeon was different. However, because both surgeons were trained and supervised by the same coauthors, this difference is considered to be small. Fourth, in the current study we performed both histological investigations and SEM instead of only SEM. This provided us with extra assessment possibilities.
The mentioned and potential other unnoted differences between both study methods could have influenced the results. However, in our opinion, the differences in study methods were not large enough to allow for ethical and cost-effective killing of 38 extra pigs to perform additional control bypasses with ELANA anastomoses.
Flap Retrieval
This is the first study in which we found a negative influence of flap retrieval failure on bypass patency. How- ever, the low number of anastomoses should be acknowledged. This finding could be coincidental, and our earlier, clinical studies showed the opposite finding.
2,11-13 Unlike in previous studies, in this one we tried to retrieve the flap manually in all cases in which it was not retrieved directly by the catheter. This procedure has not been standard in clinical studies until now, and the influence of this procedure on bypass patency has never been investigated. It is conceivable that moving microinstruments into the anastomosis could have a more negative influence on patency than the flap remaining in situ and setting itself onto the wall of the donor or recipient vessel. However, definitive recommendations based on these data cannot be given.
It is also noteworthy that no bypass occlusions occurred in the final 15 bypasses. A learning curve could theoretically have influenced bypass patency.
Arterial Remodeling
The arterial remodeling observed in the long-term survival groups in this study was identical to the remodeling in the previous ELANA pig study. We consider this to be a hemodynamic effect, combined with substantial growth of the pigs. The remodeling effect has been previously described and visualized in a study by Buijsrogge et al. 3 In this study, an intima-media apposition was used, identical to the apposition of the ELANA technique, to create beating-heart coronary bypasses in pigs. These investigators' conclusions support our finding that this effect is of no influence to the flow and patency of these anastomoses.
Future Studies
We chose to test the SELANA device in this study on an autologous bypass graft (the contralateral CCA), the endothelium of which was not touched during ring attachment to the bypass graft, and during application on the CCA. In this way, the effect of the SELANA device itself on patency was not blurred by the effect of endothelial damage, or the effect of eventual failure of artificial vessels to endothelialize. However, future research should be aimed at the development of SELANA combined with an ideal artificial vessel, because this prevents a second incision to harvest a graft. Moreover, this autologous bypass graft potentially can be of low quality, especially in patients in whom cerebral revascularization is necessary.
Buijsrogge et al., 3 and in a separate article Borst and Gründeman, 1 stated that in off-pump and endoscopic coronary bypass surgery, a need exists for a simple, timesaving, and reliable facilitated distal anastomosis procedure to replace the technically demanding manual suturing process. The SELANA technique in its current form can certainly meet these criteria. Therefore, future SELANA research should also be aimed at adapting the SELANA technique to facilitate a cardiac bypass.
